Latest Articles

Publication Date
[Endometriose i klinisk praksis].

Endometriosis is a chronic, estrogen-dependent inflammatory disorder affecting ~10% of reproductive-age women. It is underdiagnosed, with delays of 5-12 years. Symptoms include dysmenorrhea, chronic pelvic pain, dyspareunia, dyschezia, dysuria, fatigue, …

Published: March 9, 2026, midnight
Effects of E2/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis.

Patients with endometriosis have greater risk of infertility, which is associated with compromised ovarian function. Dysfunction in follicular granulosa cells and hyperactivation of oestrogen receptor beta (ERβ) are evident in …

Published: March 6, 2026, midnight
Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence - The ASCO Post

Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence The ASCO Post

Published: March 5, 2026, 4:20 p.m.
Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence - Contemporary OB/GYN

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence Contemporary OB/GYN

Published: March 5, 2026, 12:23 a.m.
Vaginal estrogen therapy not linked to cancer recurrence in survivors of endometrial cancer - Medical Xpress

Vaginal estrogen therapy not linked to cancer recurrence in survivors of endometrial cancer Medical Xpress

Published: March 4, 2026, 11:40 p.m.
Is Vaginal Estrogen Safe After Endometrial Cancer? - Medscape

Is Vaginal Estrogen Safe After Endometrial Cancer? Medscape

Published: March 4, 2026, 5:49 p.m.
Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds - News-Medical

Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds News-Medical

Published: March 4, 2026, 2:18 p.m.
Vaginal Estrogen Safe for Endometrial Cancer Survivors - Mirage News

Vaginal Estrogen Safe for Endometrial Cancer Survivors Mirage News

Published: March 4, 2026, 5:04 a.m.
Endometriomas are heterogeneous for functional FSH receptor expression and steroidogenic function.

We investigated whether ovarian endometriomas uniformly express functional FSH receptors (FSHR) and respond to FSH by activating transcriptional programs that drive aromatase and steroid hormone production. Endometrioma cyst capsules were …

Published: Feb. 27, 2026, midnight
Systems-level actions of luteolin in female reproductive disorders: from molecular mechanisms to clinical translation.

Female reproductive disorders represent a major global health challenge. Despite their clinical heterogeneity, these conditions share core pathological mechanisms including oxidative stress, chronic inflammation, hormonal imbalance, metabolic dysfunction, extracellular matrix …

Published: Feb. 25, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!